Document:

EX-10.8

 Exhibit 10.8 

INDEMNITY AGREEMENT 

THIS INDEMNITY AGREEMENT (this “Agreement”) is made as of [•], by and between Israel Amplify Program
Corp., a Cayman Islands exempted company (the “Company”), and [                ] (the “Indemnitee”). 

WHEREAS, highly competent persons have become more reluctant to serve publicly-held companies as directors, officers or in other
capacities unless they are provided with adequate protection through insurance or adequate indemnification against inordinate risks of claims and actions against them arising out of their service to and activities on behalf of such companies; 

WHEREAS, the uncertainties relating to such insurance and to indemnification have increased the difficulty of attracting and retaining
such persons; 
 WHEREAS, the Board of Directors of the Company (the “Board”) has determined that, in order
to attract and retain qualified individuals, the Company will attempt to maintain on an ongoing basis, at its sole expense, liability insurance to protect persons serving the Company and its subsidiaries from certain liabilities. The amended and
restated memorandum and articles of association of the Company (the “Articles”) provide for the indemnification of the officers and directors of the Company. The Indemnitee may also be entitled to indemnification pursuant to
applicable Cayman Islands law. The Articles provide that the indemnification provisions set forth therein are not exclusive, and thereby contemplate that contracts may be entered into between the Company and members of the Board, officers and other
persons with respect to indemnification, hold harmless, exoneration, advancement and reimbursement rights; 
 WHEREAS, the Board has
determined that the increased difficulty in attracting and retaining such persons is detrimental to the best interests of the Company’s shareholders and that the Company should act to assure such persons that there will be increased certainty
of such protection in the future; 
 WHEREAS, it is reasonable, prudent and necessary for the Company contractually to obligate
itself to indemnify, hold harmless, exonerate and to advance expenses on behalf of, such persons to the fullest extent permitted by applicable law so that they will serve or continue to serve the Company free from undue concern that they will not be
so protected against liabilities; 
 WHEREAS, this Agreement is a supplement to and in furtherance of the Articles of the Company and
any resolutions adopted pursuant thereto, and shall not be deemed a substitute therefor, nor to diminish or abrogate any rights of the Indemnitee thereunder; and 

WHEREAS, the Indemnitee may not be willing to serve as an officer or director, advisor or in another capacity without adequate
protection, and the Company desires that the Indemnitee serve in such capacity. The Indemnitee is willing to serve, continue to serve and to take on additional service for or on behalf of the Company on the condition that the Indemnitee be so
indemnified. 
 NOW, THEREFORE, in consideration of the premises and the covenants contained herein and subject to the provisions of
that certain letter agreement, dated as of [•], 2021 (commonly referred to as an “Insider Letter”), among the Company, the Indemnitee and the other parties thereto, the Company and Indemnitee do hereby covenant and agree as follows:

 1. SERVICES TO THE COMPANY 
 In
consideration of the Company’s covenants and obligations hereunder and for other good and valuable consideration, the Indemnitee will serve or continue to serve as an officer, director, advisor, key employee or in any other capacity of the
Company, as applicable, for so long as the Indemnitee is duly elected, appointed or retained or until the Indemnitee tenders the Indemnitee’s resignation or until the Indemnitee is removed. The foregoing notwithstanding, this Agreement shall
continue in full force and effect after the Indemnitee has ceased to serve as a director, officer, advisor, key employee or in any other capacity of the Company, as provided in Section 17. This Agreement, however, shall not impose any
obligation on the Indemnitee or the Company to continue the Indemnitee’s service to the Company beyond any period otherwise required by law or by other agreements or commitments of the parties hereto, if any. 

 2. DEFINITIONS 

As used in this Agreement: 
 2.1.
“Agent” shall mean any person who is or was a director, officer or employee of the Company or a subsidiary of the Company or other person authorized by the Company to act for the Company, to include such person serving in
such capacity as a director, officer, employee, advisor, fiduciary or other official of another corporation, partnership, limited liability company, joint venture, trust or other enterprise at the request of, for the convenience of, or to represent
the interests of the Company or a subsidiary of the Company. 
 2.2. “Beneficial Owner” and “Beneficial
Ownership” shall have the meanings set forth in Rule 13d-3 promulgated under the Exchange Act as in effect on the date hereof. 

2.3. “Change in Control” shall mean the occurrence of any of the following events after the date of this Agreement:

 (i) Acquisition of Shares by Third Party. Other than AOP SPAC, Limited Partnership (“AOP”), ISAP
Acquisition LP (“ISAP-Caymans”), Pitango Acquisition Corporation Limited Partnership (“Pitango”), Sphera SPAC, Limited Partnership (“Sphera”, and together with AOP, ISAP-Caymans
and Pitango, the “Sponsors”), [Blackrock, Inc.]1 or any of their respective affiliates, any Person is or becomes the Beneficial Owner, directly or indirectly, of securities
of the Company representing 15% or more of the combined voting power of the Company’s then-outstanding securities entitled to vote generally in the election of directors, unless (1) the change in the relative Beneficial Ownership of the
Company’s securities by any Person results solely from a reduction in the aggregate number of outstanding shares of securities entitled to vote generally in the election of directors, or (2) such acquisition was approved in advance by the
Continuing Directors and such acquisition would not constitute a Change in Control under clause (iii) of this definition; 
 (ii)
Change in Board of Directors. Individuals who, as of the date hereof, constitute the Board, and any new director whose election by the Board or nomination for election by the Company’s shareholders was approved by a vote of at least two
thirds of the directors then still in office who were directors on the date hereof or whose election or nomination for election was previously so approved (collectively, the “Continuing Directors”), cease for any reason to
constitute at least a majority of the members of the Board; 
 (iii) Corporate Transactions. The effective date of a merger, share
exchange, asset acquisition, share purchase, reorganization or similar business combination, involving the Company and one or more businesses (a “Business Combination”), in each case, unless, following such Business
Combination: (1) all or substantially all of the individuals and entities who were the Beneficial Owners of securities entitled to vote generally in the election of directors immediately prior to such Business Combination beneficially own,
directly or indirectly, more than 50% of the combined voting power of the then outstanding securities of the Company entitled to vote generally in the election of directors resulting from such Business Combination (including, without limitation, a
corporation which as a result of such transaction owns the Company or all or substantially all of the Company’s assets either directly or through one or more Subsidiaries) in substantially the same proportions as their ownership immediately
prior to such Business Combination, of the securities entitled to vote generally in the election of directors; (2) other than an affiliate of any Sponsor or [BlackRock, Inc.], no Person (excluding any company or corporation resulting from such
Business Combination) is the Beneficial Owner, directly or indirectly, of 15% or more of the combined voting power of the then outstanding securities entitled to vote generally in the election of directors of the surviving company or corporation
except to the extent that such ownership existed prior to the Business Combination; and (3) at least a majority of the board of directors of the company or corporation resulting from such Business Combination were Continuing Directors at the
time of the execution of the initial agreement, or of the action of the Board, providing for such Business Combination; 
  

	1 	 Note to Draft: B.C to be updated. 

 (iv) Liquidation. The approval by the shareholders of the Company of a complete
liquidation of the Company or an agreement or series of agreements for the sale or disposition by the Company of all or substantially all of the Company’s assets, other than factoring the Company’s current receivables or escrows due (or,
if such approval is not required, the decision by the Board to proceed with such a liquidation, sale, or disposition in one transaction or a series of related transactions); or 

(v) Other Events. There occurs any other event of a nature that would be required to be reported in response to Item 6(e) of Schedule
14A of Regulation 14A (or any successor rule) (or a response to any similar item on any similar schedule or form) promulgated under the Exchange Act, whether or not the Company is then subject to such reporting requirement. 

2.4. “Corporate Status” shall mean the status of a person who is or was a director, officer, trustee, general partner,
manager, managing member, fiduciary, employee or agent of the Company or of any other Enterprise which such person is or was serving at the request of the Company. 

2.5 “Delaware Court” shall mean the Court of Chancery of the State of Delaware. 

2.6. “Disinterested Director” shall mean a director of the Company who is not and was not a party to the Proceeding in
respect of which indemnification is sought by the Indemnitee. 
 2.7. “Enterprise” shall mean the Company and any
other company or corporation, constituent company or corporation (including any constituent of a constituent) absorbed in a consolidation or merger to which the Company (or any of its wholly owned subsidiaries) is a party, limited liability company,
partnership, joint venture, trust, employee benefit plan or other enterprise of which Indemnitee is or was serving at the request of the Company as a director, officer, trustee, general partner, manager, managing member, fiduciary, employee or
agent. 
 2.8. “Exchange Act” shall mean the Securities Exchange Act of 1934, as amended. 

2.9. “Expenses” shall include all direct and indirect costs, fees and expenses of any type or nature whatsoever,
including, without limitation, all reasonable attorneys’ fees and costs, retainers, court costs, transcript costs, fees of experts, witness fees, travel expenses, fees of private investigators and professional advisors, duplicating costs,
printing and binding costs, telephone charges, postage, delivery service fees, fax transmission charges, secretarial services and all other disbursements, obligations or expenses in connection with prosecuting, defending, preparing to prosecute or
defend, investigating, being or preparing to be a witness in, settlement or appeal of, or otherwise participating in, a Proceeding, including reasonable compensation for time spent by the Indemnitee for which he or she is not otherwise compensated
by the Company or any third party. “Expenses” also shall include Expenses incurred in connection with any appeal resulting from any Proceeding, including without limitation the principal, premium, security for, and other
costs relating to any cost bond, supersedeas bond, or other appeal bond or its equivalent. Expenses, however, shall not include amounts paid in settlement by the Indemnitee or the amount of judgments or fines against the Indemnitee. 

2.10. References to “fines” shall include any excise tax assessed on the Indemnitee with respect to any employee
benefit plan. 
 2.11. “Independent Counsel” shall mean a law firm or a member of a law firm with significant
experience in matters of corporate law and that neither presently is, nor in the past five years has been, retained to represent: (i) the Company or the Indemnitee in any matter material to either such party (other than with respect to matters
concerning the Indemnitee under this Agreement, or of other indemnitees under similar indemnification agreements); or (ii) any other party to the Proceeding giving rise to a claim for indemnification hereunder. Notwithstanding the foregoing,
the term “Independent Counsel” shall not include any person who, under the applicable standards of professional conduct then prevailing, would have a conflict of interest in representing either the Company or the Indemnitee
in an action to determine the Indemnitee’s rights under this Agreement. 
 2.12. “Person” shall have the
meaning as set forth in Sections 13(d) and 14(d) of the Exchange Act as in effect on the date hereof; provided, however, that “Person” shall exclude: (i) the Company; (ii) any Subsidiaries of the Company;
(iii) any employment benefit plan of the Company or of a Subsidiary of the Company or of any company or corporation owned, directly or indirectly, by the shareholders of the Company in substantially the same proportions as their ownership of
shares of the Company; and (iv) any trustee or other fiduciary holding securities under an employee benefit plan of the Company or of a Subsidiary of the Company or of a company or corporation owned directly or indirectly by the shareholders of
the Company in substantially the same proportions as their ownership of shares of the Company. 

 2.13. “Proceeding” shall mean any threatened, pending or completed
action, suit, arbitration, mediation, alternate dispute resolution mechanism, investigation, inquiry, administrative hearing or any other actual, threatened or completed proceeding, whether brought in the right of the Company or otherwise and
whether of a civil (including intentional or unintentional tort claims), criminal, administrative or investigative or related nature, in which the Indemnitee was, is, will or might be involved as a party or otherwise by reason of the fact that the
Indemnitee is or was a director or officer of the Company, by reason of any action (or failure to act) taken by the Indemnitee or of any action (or failure to act) on the Indemnitee’s part while acting as a director or officer of the Company,
or by reason of the fact that the Indemnitee is or was serving at the request of the Company as a director, officer, trustee, manager, general partner, managing member, fiduciary, employee or agent of any other Enterprise, in each case whether or
not serving in such capacity at the time any liability or expense is incurred for which indemnification, reimbursement, or advancement of expenses can be provided under this Agreement. 

2.14. References to “serving at the request of the Company” shall include any service as a director, officer,
employee, agent or fiduciary of the Company which imposes duties on, or involves services by, such director, officer, employee, agent or fiduciary with respect to an employee benefit plan, its participants or beneficiaries; and if the Indemnitee
acted in good faith and in a manner the Indemnitee reasonably believed to be in the best interests of the participants and beneficiaries of an employee benefit plan, the Indemnitee shall be deemed to have acted in a manner “not opposed to
the best interests of the Company” as referred to in this Agreement. 
 2.15. “Subsidiary” shall mean,
with respect to any Person, any company or corporation, limited liability company, partnership, joint venture, trust or other entity of which a majority of the voting power of the voting equity securities or equity interest is owned, directly or
indirectly, by that Person. 
 2.16. The phrase “to the fullest extent permitted by applicable law” shall include,
but not be limited to: (a) to the fullest extent authorized or permitted by the provision of applicable Cayman Islands law that authorizes or contemplates additional indemnification by agreement, or the corresponding provision of any amendment
to or replacement of applicable Cayman Islands law, and (b) to the fullest extent authorized or permitted by any amendments to or replacements of applicable Cayman Islands law adopted after the date of this Agreement that increase the extent to
which a company or corporation may indemnify its officers and directors. 
 3. INDEMNITY IN THIRD-PARTY PROCEEDINGS 

To the fullest extent permitted by applicable law and the Articles, the Company shall indemnify, hold harmless and exonerate the Indemnitee in
accordance with the provisions of this Section 3 if the Indemnitee was, is, or is threatened to be made, a party to or a participant (as a witness, deponent or otherwise) in any Proceeding, other than a Proceeding by or in the right of the
Company to procure a judgment in its favor by reason of the Indemnitee’s Corporate Status. Pursuant to this Section 3, the Indemnitee shall be indemnified, held harmless and exonerated against all Expenses, judgments, liabilities, fines,
penalties and amounts paid in settlement (including all interest, assessments and other charges paid or payable in connection with or in respect of such Expenses, judgments, liabilities, fines, penalties and amounts paid in settlement) actually, and
reasonably incurred by the Indemnitee or on the Indemnitee’s behalf in connection with such Proceeding or any claim, issue or matter therein, if the Indemnitee acted in good faith and in a manner the Indemnitee reasonably believed to be in, or
not opposed to, the best interests of the Company and, in the case of a criminal Proceeding, had no reasonable cause to believe that the Indemnitee’s conduct was unlawful; provided that in no event shall the Indemnitee be entitled to be
indemnified, held harmless or advanced any amounts hereunder in respect of any Expenses, judgments, liabilities, fines, penalties and amounts paid in settlement (if any) that the Indemnitee may incur by reason of the Indemnitee’s own actual
fraud, wilful default or wilful neglect. The Indemnitee shall not be found to have committed actual fraud, wilful default or wilful neglect for any purpose of this Agreement unless or until a court of competent jurisdiction shall have made a finding
to that effect. 

 4. INDEMNITY IN PROCEEDINGS BY OR IN THE RIGHT OF THE COMPANY 

To the fullest extent permitted by applicable law and the Articles, the Company shall indemnify, hold harmless and exonerate the Indemnitee in
accordance with the provisions of this Section 4 if the Indemnitee was, is, or is threatened to be made, a party to or a participant (as a witness, deponent or otherwise) in any Proceeding by or in the right of the Company to procure a judgment
in its favor by reason of the Indemnitee’s Corporate Status. Pursuant to this Section 4, the Indemnitee shall be indemnified, held harmless and exonerated against all Expenses actually and reasonably incurred by the Indemnitee or on the
Indemnitee’s behalf in connection with such Proceeding or any claim, issue or matter therein, if the Indemnitee acted in good faith and in a manner the Indemnitee reasonably believed to be in, or not opposed to, the best interests of the
Company. The Indemnitee shall not be entitled to be indemnified, held harmless or exonerated for Expenses under this Section 4 in respect of any claim, issue or matter as to which the Indemnitee shall have been finally adjudged by a court of
competent jurisdiction to be liable to the Company, unless and only to the extent that any court in which the Proceeding was brought or the Delaware Court shall determine upon application that, despite the adjudication of liability but in view of
all the circumstances of the case, the Indemnitee is fairly and reasonably entitled to indemnification, to be held harmless or to exoneration. 
 5.
INDEMNIFICATION FOR EXPENSES OF A PARTY WHO IS WHOLLY OR PARTLY SUCCESSFUL 
 Notwithstanding any other provisions of this Agreement
other than Section 27, to the extent that the Indemnitee was or is, by reason of the Indemnitee’s Corporate Status, a party to (or a participant in) and is successful, on the merits or otherwise, in any Proceeding or in defense of any
claim, issue or matter therein, in whole or in part, the Company shall, to the fullest extent permitted by applicable law and the Articles, indemnify, hold harmless and exonerate the Indemnitee against all Expenses actually and reasonably incurred
by the Indemnitee in connection therewith. If the Indemnitee is not wholly successful in such Proceeding but is successful, on the merits or otherwise, as to one or more but less than all claims, issues or matters in such Proceeding, the Company
shall, to the fullest extent permitted by applicable law and the Articles, indemnify, hold harmless and exonerate the Indemnitee against all Expenses actually and reasonably incurred by the Indemnitee or on the Indemnitee’s behalf in connection
with each successfully resolved claim, issue or matter. If the Indemnitee is not wholly successful in such Proceeding, the Company also shall, to the fullest extent permitted by applicable law and the Articles, indemnify, hold harmless and exonerate
the Indemnitee against all Expenses reasonably incurred in connection with a claim, issue or matter related to any claim, issue, or matter on which the Indemnitee was successful. For purposes of this Section 5 and without limitation, the
termination of any claim, issue or matter in such a Proceeding by dismissal, with or without prejudice, shall be deemed to be a successful result as to such claim, issue or matter. 

6. INDEMNIFICATION FOR EXPENSES OF A WITNESS 

Notwithstanding any other provision of this Agreement other than Section 27, to the extent that the Indemnitee is, by reason of the
Indemnitee’s Corporate Status, a witness or deponent in any Proceeding to which the Indemnitee is not a party or threatened to be made a party, the Indemnitee shall, to the fullest extent permitted by applicable law and the Articles, be
indemnified, held harmless and exonerated against all Expenses actually and reasonably incurred by the Indemnitee or on the Indemnitee’s behalf in connection therewith. 

7. ADDITIONAL INDEMNIFICATION, HOLD HARMLESS AND EXONERATION RIGHTS 

Notwithstanding any limitation in Sections 3, 4 or 5, but subject to Section 27, the Company shall, to the fullest extent permitted by
applicable law and the Articles, indemnify, hold harmless and exonerate the Indemnitee if the Indemnitee is a party to or threatened to be made a party to any Proceeding (including a Proceeding by or in the right of the Company to procure a judgment
in its favor) against all Expenses, judgments, liabilities, fines, penalties and amounts paid in settlement (including all interest, assessments and other charges paid or payable in connection with or in respect of such Expenses, judgments,
liabilities, fines, penalties and amounts paid in settlement) actually and reasonably incurred by the Indemnitee in connection with the Proceeding. The Indemnitee shall not be entitled to be indemnified, held harmless or exonerated under this
Section 7 in the event that the Indemnitee’s conduct is finally adjudged by a court of competent jurisdiction to constitute a breach of the Indemnitee’s duty of loyalty to the Company or its shareholders or is an act or omission not
in good faith or which involves intentional misconduct or a knowing violation of applicable law. 

 8. CONTRIBUTION IN THE EVENT OF JOINT LIABILITY 

8.1. To the fullest extent permitted by applicable law and the Articles, if the indemnification, hold harmless and/or exoneration rights
provided for in this Agreement are unavailable to the Indemnitee in whole or in part for any reason whatsoever, the Company, in lieu of indemnifying, holding harmless or exonerating the Indemnitee, shall pay, in the first instance, the entire amount
incurred by the Indemnitee, whether for judgments, liabilities, fines, penalties, amounts paid or to be paid in settlement and/or for Expenses, in connection with any Proceeding without requiring the Indemnitee to contribute to such payment, and the
Company hereby waives and relinquishes any right of contribution it may have at any time against the Indemnitee. 
 8.2. The Company shall
not enter into any settlement of any Proceeding in which the Company is jointly liable with the Indemnitee (or would be if joined in such Proceeding) unless such settlement (1) includes an express and unconditional release of the Indemnitee, in
form and substance reasonable satisfactory to the Indemnitee, from all liability arising out of such Proceeding and (2) does not include a statement as to, or an admission of, fault, culpability or a failure to act by or on behalf of the
Indemnitee. 
 8.3. The Company hereby agrees to fully indemnify, hold harmless and exonerate the Indemnitee from any claims for
contribution which may be brought by officers, directors or employees of the Company other than the Indemnitee who may be jointly liable with the Indemnitee. The Indemnitee shall seek payments or advances from the Company only to the extent that
such payments or advances are unavailable from any insurance policy of the Company covering the Indemnitee. 
 9. EXCLUSIONS 

Notwithstanding any provision in this Agreement, the Company shall not be obligated under this Agreement to indemnify, hold harmless, exonerate
or advance Expenses in connection with any claim made against the Indemnitee: 
 (i) for which payment has actually been received by or on
behalf of the Indemnitee under any insurance policy or other indemnity or advancement provision and which payment has not subsequently been returned, except with respect to any excess beyond the amount actually received under any insurance policy,
contract, agreement, other indemnity or advancement provision or otherwise; 
 (ii) for an accounting or disgorgement of profits made from
the purchase and sale (or sale and purchase) by the Indemnitee of securities of the Company within the meaning of Section 16(b) of the Exchange Act (or any successor rule) or similar provisions of state statutory law or common law; or 

(iii) except as otherwise provided in Sections 14.6 and 14.7 hereof, prior to a Change in Control, in connection with any Proceeding (or any
part of any Proceeding) initiated by the Indemnitee, including any Proceeding (or any part of any Proceeding) initiated by the Indemnitee against the Company or its directors, officers, employees or other indemnitees, unless (i) the Board
authorized the Proceeding (or any part of any Proceeding) prior to its initiation or (ii) the Company provides the indemnification, hold harmless or exoneration payment, in its sole discretion, pursuant to the powers vested in the Company under
applicable law and the Articles. 
 10. ADVANCES OF EXPENSES; DEFENSE OF CLAIM 

10.1. Notwithstanding any provision of this Agreement to the contrary other than Section 27, and to the fullest extent not prohibited by
applicable law and the Articles, the Company shall pay the Expenses incurred by the Indemnitee (or reasonably expected by the Indemnitee to be incurred by the Indemnitee within three months) in connection with any Proceeding within 10 days after the
receipt by the Company of a statement or statements requesting such advances from time to time, prior to the final disposition of any Proceeding. Advances shall, to the fullest extent permitted by applicable law, be unsecured and interest free.
Advances shall, to the fullest extent permitted by applicable law, be made without regard to the Indemnitee’s ability to repay the Expenses and without regard to the Indemnitee’s ultimate entitlement to be indemnified, held harmless or
exonerated under the other provisions of this Agreement. Advances shall include any and all reasonable Expenses incurred pursuing a Proceeding to enforce this right of advancement, including Expenses incurred preparing and forwarding statements to
the Company to support the advances claimed. To the fullest extent required by applicable law, such payments of Expenses in advance of the final disposition of the Proceeding shall be made only upon the Company’s receipt of an undertaking, by
or on behalf of the Indemnitee, to repay the advanced amounts to the extent that it is ultimately 

 
determined that the Indemnitee is not entitled to be indemnified, held harmless or exonerated by the Company under the provisions of this Agreement, applicable law and the Articles or otherwise.
If it shall be determined by a final judgment or other final adjudication that the Indemnitee was not so entitled to indemnification, any advancement shall be returned to the Company (without interest) by the Indemnitee. This Section 10.1 shall
not apply to any claim made by the Indemnitee for which an indemnification, hold harmless or exoneration payment is excluded pursuant to Section 9, but shall apply to any Proceeding referenced in Section 9(ii) prior to a final
determination that the Indemnitee is liable therefor. 
 10.2. The Company will be entitled to participate in the Proceeding at its own
expense. 
 10.3. The Company shall not settle any action, claim or Proceeding (in whole or in part) which would impose any Expense,
judgment, liability, fine, penalty or limitation on the Indemnitee without the Indemnitee’s prior written consent. 
 11. PROCEDURE FOR NOTIFICATION
AND APPLICATION FOR INDEMNIFICATION 
 11.1. The Indemnitee agrees to notify promptly the Company in writing upon being served with any
summons, citation, subpoena, complaint, indictment, information or other document relating to any Proceeding, claim, issue or matter therein which may be subject to indemnification, hold harmless or exoneration rights, or advancement of Expenses
covered hereunder. The failure of the Indemnitee to so notify the Company shall not relieve the Company of any obligation which it may have to the Indemnitee under this Agreement, or otherwise. 

11.2. The Indemnitee may deliver to the Company a written application to indemnify, hold harmless or exonerate the Indemnitee in accordance
with this Agreement. Such application(s) may be delivered from time to time and at such time(s) as the Indemnitee deems appropriate in his or her sole discretion. Following such a written application for indemnification by the Indemnitee, the
Indemnitee’s entitlement to indemnification shall be determined according to Section 12.1 of this Agreement. 
 12. PROCEDURE UPON APPLICATION
FOR INDEMNIFICATION 
 12.1. A determination, if required by applicable law or the Articles, with respect to the Indemnitee’s
entitlement to indemnification shall be made in the specific case by one of the following methods, which shall be at the election of the Indemnitee: (i) by a majority vote of the Disinterested Directors, even though less than a quorum of the
Board, (ii) by a committee of Disinterested Directors designated by a majority vote of the Disinterested Directors, even though less than a quorum of the Board, (iii) if there are no Disinterested Directors or if such Disinterested
Directors so direct, by an Independent Counsel in a written opinion to the Board, a copy of which shall be delivered to the Indemnitee, or (iv) by vote of the shareholders by ordinary resolution. The Company promptly will advise the Indemnitee
in writing with respect to any determination that the Indemnitee is or is not entitled to indemnification, including a description of any reason or basis for which indemnification has been denied. If it is so determined that the Indemnitee is
entitled to indemnification, payment to the Indemnitee shall be made within 10 days after such determination. The Indemnitee shall reasonably cooperate with the person, persons or entity making such determination with respect to the
Indemnitee’s entitlement to indemnification, including providing to such person, persons or entity upon reasonable advance request any documentation or information which is not privileged or otherwise protected from disclosure and which is
reasonably available to the Indemnitee and reasonably necessary to such determination. Any costs or Expenses (including reasonable attorneys’ fees and disbursements) incurred by the Indemnitee in so cooperating with the person, persons or
entity making such determination shall be borne by the Company (irrespective of the determination as to the Indemnitee’s entitlement to indemnification) and the Company hereby agrees to indemnify and to hold the Indemnitee harmless therefrom.

 12.2. In the event the determination of entitlement to indemnification is to be made by an Independent Counsel pursuant to
Section 12.1 hereof, the Independent Counsel shall be selected as provided in this Section 12.2. The Independent Counsel shall be selected by the Indemnitee (unless the Indemnitee shall request that such selection be made by the Board),
and the Indemnitee shall give written notice to the Company advising it of the identity of the Independent Counsel so selected and certifying that the Independent Counsel so selected meets the requirements of “Independent
Counsel” as defined in Section 2.11 of this Agreement. If the Independent Counsel is selected by the Board, the Company shall give written notice to the Indemnitee advising the Indemnitee of the identity of the

 
Independent Counsel so selected and certifying that the Independent Counsel so selected meets the requirements of “Independent Counsel” as defined in Section 2.11 of
this Agreement. In either event, the Indemnitee or the Company, as the case may be, may, within 10 days after such written notice of selection shall have been received, deliver to the Company or to the Indemnitee, as the case may be, a written
objection to such selection; provided, however, that such objection may be asserted only on the ground that the Independent Counsel so selected does not meet the requirements of “Independent Counsel” as defined
in Section 2.11 of this Agreement, and the objection shall set forth with particularity the factual basis of such assertion. Absent a proper and timely objection, the person so selected shall act as the Independent Counsel for such
determination as to the Indemnitee’s entitlement to indemnification. If such written objection is so made and substantiated, the law firm or member of a law firm so selected may not serve as Independent Counsel unless and until such objection
is withdrawn or a court of competent jurisdiction has determined that such objection is without merit. If, within 20 days after submission by the Indemnitee of a written request for indemnification pursuant to Section 11.2 hereof, no
Independent Counsel shall have been selected and not objected to, either the Company or the Indemnitee may petition the Delaware Court for resolution of any objection which shall have been made by the Company or the Indemnitee to the other’s
selection of Independent Counsel and/or for the appointment as Independent Counsel of a person selected by the Delaware Court, and the person with respect to whom all objections are so resolved or the person so appointed shall act as Independent
Counsel under Section 12.1 hereof. Upon the due commencement of any judicial proceeding or arbitration pursuant to Section 14.1 of this Agreement, the Independent Counsel shall be discharged and relieved of any further responsibility in
such capacity (subject to the applicable standards of professional conduct then prevailing). 
 12.3. The Company agrees to pay the
reasonable fees and expenses of the Independent Counsel and to fully indemnify and hold harmless such Independent Counsel against any and all Expenses, claims, liabilities and damages arising out of or relating to this Agreement or its engagement
pursuant hereto. 
 13. PRESUMPTIONS AND EFFECT OF CERTAIN PROCEEDINGS 

13.1. In making a determination with respect to the Indemnitee’s entitlement to indemnification hereunder, the person, persons or entity
making such determination shall presume that the Indemnitee is entitled to indemnification under this Agreement if the Indemnitee has submitted a request for indemnification in accordance with Section 11.2 of this Agreement, and the Company
shall have the burden of proof to overcome that presumption in connection with the making by any person, persons or entity of any determination contrary to that presumption. Neither the failure of the Company (including by the Disinterested
Directors or the Independent Counsel) to have made a determination prior to the commencement of any action pursuant to this Agreement that indemnification is proper in the circumstances because the Indemnitee has met the applicable standard of
conduct, nor an actual determination by the Company (including by the Disinterested Directors or the Independent Counsel) that the Indemnitee has not met such applicable standard of conduct, shall be a defense to the action or create a presumption
that the Indemnitee has not met the applicable standard of conduct. 
 13.2. If the person, persons or entity empowered or selected under
Section 12 of this Agreement to determine whether the Indemnitee is entitled to indemnification shall not have made a determination within 30 days after receipt by the Company of the request therefor, the requisite determination of entitlement
to indemnification shall, to the fullest extent permitted by applicable law and the Articles, be deemed to have been made and the Indemnitee shall be entitled to such indemnification, absent (i) a misstatement by the Indemnitee of a material
fact, or an omission of a material fact necessary to make the Indemnitee’s statement not materially misleading, in connection with the request for indemnification, or (ii) a final judicial determination that any or all such indemnification
is expressly prohibited under applicable law or the Articles; provided, however, that such 30-day period may be extended for a reasonable time, not to exceed an additional 15 days, if the person,
persons or entity making the determination with respect to entitlement to indemnification in good faith requires such additional time for the obtaining or evaluating of documentation and/or information relating thereto. 

13.3. The termination of any Proceeding or of any claim, issue or matter therein, by judgment, order, settlement or conviction, or upon a plea
of nolo contendere or its equivalent, shall not (except as otherwise expressly provided in this Agreement) of itself adversely affect the right of the Indemnitee to indemnification or create a presumption that the Indemnitee did not act in good
faith and in a manner which the Indemnitee reasonably believed to be in, or not opposed to, the best interests of the Company or, with respect to any criminal Proceeding, that the Indemnitee had reasonable cause to believe that the Indemnitee’s
conduct was unlawful. 

 13.4. For purposes of any determination of good faith, the Indemnitee shall be deemed to
have acted in good faith if the Indemnitee’s actions or omissions were taken in good faith reliance upon the records or books of account of the Enterprise, including financial statements, or on information supplied to the Indemnitee by the
directors, managers, managing members or officers of the Enterprise in the course of their duties, or on the advice of legal counsel for the Enterprise, its Board, any committee of the Board or any director, trustee, general partner, manager or
managing member, or on information or records given or reports made to the Enterprise, its Board, any committee of the Board or any director, trustee, general partner, manager or managing member, by an independent certified public accountant or by
an appraiser or other expert selected by the Enterprise, its Board, any committee of the Board or any director, trustee, general partner, manager or managing member. The provisions of this Section 13.4 shall not be deemed to be exclusive or to
limit in any way the other circumstances in which the Indemnitee may be deemed or found to have met the applicable standard of conduct set forth in this Agreement. 

13.5. The knowledge and/or actions, or failure to act, of any other director, officer, trustee, partner, manager, managing member, fiduciary,
agent or employee of the Enterprise shall not be imputed to the Indemnitee for purposes of determining the right to indemnification under this Agreement. 

14. REMEDIES OF INDEMNITEE 
 14.1. In the
event that (i) a determination is made pursuant to Section 12 of this Agreement that the Indemnitee is not entitled to indemnification under this Agreement, (ii) advancement of Expenses, to the fullest extent permitted by applicable
law and the Articles, is not timely made pursuant to Section 10 of this Agreement, (iii) no determination of entitlement to indemnification shall have been made pursuant to Section 12.1 of this Agreement within 30 days after receipt
by the Company of the request for indemnification (or within 15 days of any extension of such 30-day period), (iv) payment of indemnification is not made pursuant to Sections 5, 6, 7 or the last sentence of
Section 12.1 of this Agreement within 10 days after receipt by the Company of a written request therefor, (v) a contribution payment is not made in a timely manner pursuant to Section 8 of this Agreement, (vi) payment of
indemnification pursuant to Sections 3 or 4 of this Agreement is not made within 10 days after a determination has been made that the Indemnitee is entitled to indemnification, or (vii) payment to the Indemnitee pursuant to any indemnification,
hold harmless or exoneration rights under this Agreement or otherwise is not made in accordance with this Agreement within 10 days after receipt by the Company of a written request therefor, the Indemnitee shall be entitled to an adjudication by the
Delaware Court to such indemnification, hold harmless, exoneration, contribution or advancement rights. Alternatively, the Indemnitee, at the Indemnitee’s option, may seek an award in arbitration to be conducted by a single arbitrator pursuant
to the Commercial Arbitration Rules and Mediation Procedures of the American Arbitration Association. Except as set forth herein, the provisions of Delaware law (without regard to its conflict of laws rules) shall apply to any such arbitration. The
Company shall not oppose the Indemnitee’s right to seek any such adjudication or award in arbitration. 
 14.2. In the event that a
determination shall have been made pursuant to Section 12.1 of this Agreement that the Indemnitee is not entitled to indemnification, any judicial proceeding or arbitration commenced pursuant to this Section 14 shall be conducted in all
respects as a de novo trial, or arbitration, on the merits and the Indemnitee shall not be prejudiced by reason of that adverse determination. 

14.3. In any judicial proceeding or arbitration commenced pursuant to this Section 14, the Indemnitee shall be presumed to be entitled to
be indemnified, held harmless and exonerated and to receive advancement of Expenses under this Agreement and the Company shall have the burden of proving the Indemnitee is not entitled to be indemnified, held harmless and exonerated and to receive
advancement of Expenses, as the case may be, and the Company may not refer to or introduce into evidence any determination pursuant to Section 12.1 of this Agreement adverse to the Indemnitee for any purpose. If the Indemnitee commences a
judicial proceeding or arbitration pursuant to this Section 14, the Indemnitee shall not be required to reimburse the Company for any advances pursuant to Section 10 until a final determination is made with respect to the Indemnitee’s
entitlement to indemnification (as to which all rights of appeal have been exhausted or lapsed). 

 14.4. If a determination shall have been made pursuant to Section 12.1 of this
Agreement that the Indemnitee is entitled to indemnification, the Company shall be bound by such determination in any judicial proceeding or arbitration commenced pursuant to this Section 14, absent (i) a misstatement by the Indemnitee of
a material fact, or an omission of a material fact necessary to make the Indemnitee’s statement not materially misleading, in connection with the request for indemnification, or (ii) a prohibition of such indemnification under applicable
law or the Articles. 
 14.5. The Company shall be precluded from asserting in any judicial proceeding or arbitration commenced pursuant to
this Section 14 that the procedures and presumptions of this Agreement are not valid, binding and enforceable and shall stipulate in any such court or before any such arbitrator that the Company is bound by all the provisions of this Agreement.

 14.6. The Company shall indemnify and hold harmless the Indemnitee to the fullest extent permitted by applicable law and the Articles
against all Expenses and, if requested by the Indemnitee, shall (within 10 days after the Company’s receipt of such written request) pay to the Indemnitee, to the fullest extent permitted by applicable law, such Expenses which are incurred by
the Indemnitee in connection with any judicial proceeding or arbitration brought by the Indemnitee: (i) to enforce the Indemnitee’s rights under, or to recover damages for breach of, this Agreement or any other indemnification, hold
harmless, exoneration, advancement or contribution agreement or provision of the Articles now or hereafter in effect; or (ii) for recovery or advances under any insurance policy maintained by any person for the benefit of the Indemnitee,
regardless of the outcome and whether the Indemnitee ultimately is determined to be entitled to such indemnification, hold harmless or exoneration right, advancement, contribution or insurance recovery, as the case may be (unless such judicial
proceeding or arbitration was not brought by the Indemnitee in good faith). 
 14.7. Interest shall be paid by the Company to the Indemnitee
at the legal rate under Delaware law for amounts which the Company indemnifies, holds harmless or exonerates, or advances, or is obliged to indemnify, hold harmless or exonerate or advance for the period commencing with the date on which the
Indemnitee requests indemnification, to be held harmless, exonerated, contribution, reimbursement or advancement of any Expenses and ending with the date on which such payment is made to the Indemnitee by the Company. 

15. SECURITY 
 Notwithstanding anything
herein to the contrary other than Section 27, to the extent requested by the Indemnitee and approved by the Board, the Company may at any time and from time to time provide security to the Indemnitee for the Company’s obligations hereunder
through an irrevocable bank line of credit, funded trust or other collateral. Any such security, once provided to the Indemnitee, may not be revoked or released without the prior written consent of the Indemnitee. 

16. NON-EXCLUSIVITY; SURVIVAL OF RIGHTS; INSURANCE; SUBROGATION; PRIORITY OF OBLIGATIONS 

16.1. The rights of the Indemnitee as provided by this Agreement shall not be deemed exclusive of any other rights to which the Indemnitee may
at any time be entitled under applicable law, the Articles, any agreement, a vote of shareholders or a resolution of directors, or otherwise. No amendment, alteration or repeal of this Agreement or of any provision hereof shall limit or restrict any
right of the Indemnitee under this Agreement in respect of any Proceeding (regardless of when such Proceeding is first threatened, commenced or completed) or claim, issue or matter therein arising out of, or related to, any action taken or omitted
by such Indemnitee in Indemnitee’s Corporate Status prior to such amendment, alteration or repeal. To the extent that a change in applicable law, whether by statute or judicial decision, permits greater indemnification, hold harmless or
exoneration rights or advancement of Expenses than would be afforded currently under the Articles or this Agreement, then this Agreement (without any further action by the parties hereto) shall automatically be deemed to be amended to require that
the Company indemnifies the Indemnitee to the fullest extent permitted by applicable law and the Articles (after giving effect for any such change in applicable law). No right or remedy herein conferred is intended to be exclusive of any other right
or remedy, and every other right and remedy shall be cumulative and in addition to every other right and remedy given hereunder or now or hereafter existing at law or in equity or otherwise. The assertion or employment of any right or remedy
hereunder, or otherwise, shall not prevent the concurrent assertion or employment of any other right or remedy. 

 16.2. The Articles and applicable law permit the Company to purchase and maintain insurance
or furnish similar protection or make other arrangements including, but not limited to, providing a trust fund, letter of credit, or surety bond (“Indemnification Arrangements”) on behalf of the Indemnitee against any
liability asserted against the Indemnitee or incurred by or on behalf of the Indemnitee or in such capacity as a director, officer, employee or agent of the Company, or arising out of the Indemnitee’s status as such, whether or not the Company
would have the power to indemnify the Indemnitee against such liability under the provisions of this Agreement and the Articles or under Cayman Islands law, as it may then be in effect. The purchase, establishment, and maintenance of any such
Indemnification Arrangement shall not in any way limit or affect the rights and obligations of the Company or of the Indemnitee under this Agreement except as expressly provided herein, and the execution and delivery of this Agreement by the Company
and the Indemnitee shall not in any way limit or affect the rights and obligations of the Company or the other party or parties thereto under any such Indemnification Arrangement. 

16.3. To the extent that the Company maintains an insurance policy or policies providing liability insurance for directors, officers,
trustees, partners, managers, managing members, fiduciaries, employees, or agents of the Company or of any other Enterprise which such person serves at the request of the Company, the Indemnitee shall be covered by such policy or policies in
accordance with its or their terms to the maximum extent of the coverage available for any such director, officer, trustee, partner, managers, managing member, fiduciary, employee or agent under such policy or policies. If, at the time the Company
receives notice from any source of a Proceeding as to which the Indemnitee is a party or a participant (as a witness, deponent or otherwise), the Company has director and officer liability insurance in effect, the Company shall give prompt notice of
such Proceeding to the insurers in accordance with the procedures set forth in the respective policies. The Company shall thereafter use commercially reasonable efforts to cause such insurers to pay, on behalf of the Indemnitee, all amounts payable
as a result of such Proceeding in accordance with the terms of such policies. 
 16.4. In the event of any payment under this Agreement, the
Company, to the fullest extent permitted by applicable law, shall be subrogated to the extent of such payment to all of the rights of recovery of the Indemnitee, who shall execute all papers required and take all action necessary to secure such
rights, including execution of such documents as are necessary to enable the Company to bring suit to enforce such rights. No such payment by the Company shall be deemed to relieve any insurer of its obligations. 

16.5. The Company’s obligation to indemnify, hold harmless, exonerate or advance Expenses hereunder to an Indemnitee who is or was
serving at the request of the Company as a director, officer, trustee, partner, manager, managing member, fiduciary, employee or agent of any other Enterprise shall be reduced by any amount the Indemnitee has actually received as indemnification (to
the extent that such amount has not subsequently been returned), hold harmless or exoneration payments or advancement of expenses from such Enterprise. Notwithstanding any other provision of this Agreement to the contrary except for Section 27,
(i) the Indemnitee shall have no obligation to reduce, offset, allocate, pursue or apportion any indemnification, hold harmless, exoneration, advancement, contribution or insurance coverage among multiple parties possessing such duties to the
Indemnitee prior to the Company’s satisfaction and performance of all its obligations under this Agreement, and (ii) the Company shall perform fully its obligations under this Agreement without regard to whether the Indemnitee holds, may
pursue or has pursued any indemnification, advancement, hold harmless, exoneration, contribution or insurance coverage rights against any person or entity other than the Company. 

17. DURATION OF AGREEMENT 
 All agreements
and obligations of the Company contained herein shall continue during the period the Indemnitee serves as a director or officer or advisor or key employee of the Company or as a director, officer, trustee, partner, manager, managing member,
fiduciary, employee or agent of any other company or corporation, partnership, joint venture, trust, employee benefit plan or other Enterprise which the Indemnitee serves at the request of the Company and shall continue thereafter so long as the
Indemnitee shall be subject to any possible Proceeding (including any rights of appeal thereto and any Proceeding commenced by the Indemnitee pursuant to Section 14 of this Agreement) by reason of the Indemnitee’s Corporate Status, whether
or not the Indemnitee is acting in any such capacity at the time any liability or expense is incurred for which indemnification or advancement can be provided under this Agreement. 

 18. SEVERABILITY 

If any provision or provisions of this Agreement shall be held to be invalid, illegal or unenforceable for any reason whatsoever: (a) the
validity, legality and enforceability of the remaining provisions of this Agreement (including, without limitation, each portion of any Section, paragraph or sentence of this Agreement containing any such provision held to be invalid, illegal or
unenforceable, that is not itself invalid, illegal or unenforceable) shall not in any way be affected or impaired thereby and shall remain enforceable to the fullest extent permitted by applicable law; (b) such provision or provisions shall be
deemed reformed to the extent necessary to conform to applicable law and to give the maximum effect to the intent of the parties hereto; and (c) to the fullest extent possible, the provisions of this Agreement (including, without limitation,
each portion of any Section, paragraph or sentence of this Agreement containing any such provision held to be invalid, illegal or unenforceable, that is not itself invalid, illegal or unenforceable) shall be construed so as to give effect to the
intent manifested thereby. 
 19. ENFORCEMENT AND BINDING EFFECT 

19.1. The Company expressly confirms and agrees that it has entered into this Agreement and assumed the obligations imposed on it hereby in
order to induce the Indemnitee to serve as a director, officer, advisor or key employee of the Company, and the Company acknowledges that the Indemnitee is relying upon this Agreement in serving as a director, officer, advisor or key employee of the
Company. 
 19.2. Without limiting any of the rights of the Indemnitee under the Articles of the Company as they may be amended from time to
time, this Agreement, together with the Insider Letter, constitutes the entire agreement between the parties hereto with respect to the subject matter hereof and supersedes all prior agreements and understandings, oral, written and implied, between
the parties hereto with respect to the subject matter hereof. 
 19.3. The indemnification, hold harmless, exoneration rights and the
advancement of Expenses provided by or granted pursuant to this Agreement shall be binding upon and be enforceable by the parties hereto and their respective successors and assigns (including any direct or indirect successor by purchase, merger,
consolidation or otherwise to all or substantially all of the business and/or assets of the Company), shall continue as to an Indemnitee who has ceased to be a director, officer, advisor, key employee or agent of the Company or a director, officer,
trustee, general partner, manager, managing member, fiduciary, employee or agent of any other Enterprise at the Company’s request, and shall inure to the benefit of the Indemnitee and the Indemnitee’s spouse, assigns, heirs, devisees,
executors and administrators and other legal representatives. 
 19.4. The Company shall require and cause any successor (whether direct or
indirect by purchase, merger, consolidation or otherwise) to all, substantially all or a substantial part, of the business and/or assets of the Company, by written agreement in form and substance satisfactory to the Indemnitee, expressly to assume
and agree to perform this Agreement in the same manner and to the same extent that the Company would be required to perform if no such succession had taken place. 

19.5. The Company and the Indemnitee agree herein that a monetary remedy for breach of this Agreement, at some later date, may be inadequate,
impracticable and difficult of proof, and further agree that such breach may cause the Indemnitee irreparable harm. Accordingly, the parties hereto agree that the Indemnitee may, to the fullest extent permitted by applicable law, enforce this
Agreement by seeking, among other things, injunctive relief and/or specific performance hereof, without any necessity of showing actual damage or irreparable harm and that by seeking injunctive relief and/or specific performance, the Indemnitee
shall not be precluded from seeking or obtaining any other relief to which the Indemnitee may be entitled. The Company and the Indemnitee further agree that the Indemnitee shall, to the fullest extent permitted by applicable law, be entitled to such
specific performance and injunctive relief, including temporary restraining orders, preliminary injunctions and permanent injunctions, without the necessity of posting bonds or other undertaking in connection therewith. The Company acknowledges that
in the absence of a waiver, a bond or undertaking may be required of the Indemnitee by a court of competent jurisdiction. The Company hereby waives any such requirement of such a bond or undertaking to the fullest extent permitted by applicable law.

 20. MODIFICATION AND WAIVER 

No supplement, modification or amendment of this Agreement shall be binding unless executed in writing by the parties hereto. No waiver of any
of the provisions of this Agreement shall be deemed or shall constitute a waiver of any other provisions of this Agreement nor shall any waiver constitute a continuing waiver. 

21. NOTICES 
 All notices, requests,
demands and other communications under this Agreement shall be in writing and shall be deemed to have been duly given (i) if delivered by hand and receipted for by the party to whom said notice or other communication shall have been directed,
upon such delivery, or (ii) if mailed by certified or registered mail with postage prepaid, on the third business day after the date on which it is so mailed: 

If to the Indemnitee, to the address indicated on the signature page of this Agreement, or such other address as the Indemnitee shall provide
in writing to the Company. 
 If to the Company, to: 

Israel Amplify Program Corp. 
 c/o
Sphera Fund 
 10 E. 53rd Street, Suite 1301, 13th Floor 

New York, New York 10022 

Attention: Asher Levy 
 With a
copy, which shall not constitute notice, to: 
 Cravath, Swaine & Moore LLP 

825 Eighth Avenue 
 New York, New
York 10019 
 Attn: Nicholas A. Dorsey & Matthew G. Jones 

or to any other address as may have been furnished to the Indemnitee in writing by the Company. 

22. APPLICABLE LAW AND CONSENT TO JURISDICTION 

This Agreement and the legal relations among the parties shall be governed by, and construed and enforced in accordance with, the laws of the
State of Delaware, without regard to its conflict of laws rules. Except with respect to any arbitration commenced by the Indemnitee pursuant to Section 14.1 of this Agreement, to the fullest extent permitted by applicable law, the Company and
the Indemnitee hereby irrevocably and unconditionally: (a) agree that any action or proceeding arising out of or in connection with this Agreement shall be brought only in the Delaware Court and not in any other state or federal court in the
United States of America or any court in any other country; (b) consent to submit to the exclusive jurisdiction of the Delaware Court for purposes of any action or proceeding arising out of or in connection with this Agreement; (c) waive
any objection to the laying of venue of any such action or proceeding in the Delaware Court; and (d) waive, and agree not to plead or to make, any claim that any such action or proceeding brought in the Delaware Court has been brought in an
improper or inconvenient forum, or is subject (in whole or in part) to a jury trial. To the fullest extent permitted by applicable law, the parties hereby agree that the mailing of process and other papers in connection with any such action or
proceeding in the manner provided by Section 21, or in such other manner as may be permitted by applicable law, shall be valid and sufficient service thereof. 

23. IDENTICAL COUNTERPARTS 
 This
Agreement may be executed in one or more counterparts (including facsimile or PDF counterparts), each of which shall for all purposes be deemed to be an original but all of which together shall constitute one and the same Agreement. Only one such
counterpart signed by the party against whom enforceability is sought needs to be produced to evidence the existence of this Agreement. 

 24. MISCELLANEOUS 

The headings of the paragraphs of this Agreement are inserted for convenience only and shall not be deemed to constitute part of this Agreement
or to affect the construction thereof. 
 25. PERIOD OF LIMITATIONS 

No legal action shall be brought and no cause of action shall be asserted by or in the right of the Company against the Indemnitee, the
Indemnitee’s spouse, heirs, executors or personal or legal representatives after the expiration of two years from the date of accrual of such cause of action, and any claim or cause of action of the Company shall be extinguished and deemed
released unless asserted by the timely filing of a legal action within such two-year period; provided, however, that if any shorter period of limitations is otherwise applicable to any such cause
of action such shorter period shall govern. 
 26. ADDITIONAL ACTS 

If for the validation of any of the provisions in this Agreement any act, resolution, approval or other procedure is required to the fullest
extent permitted by applicable law, the Company undertakes to cause such act, resolution, approval or other procedure to be affected or adopted in a manner that will enable the Company to fulfill its obligations under this Agreement. 

27. WAIVER OF CLAIMS TO TRUST ACCOUNT 

Notwithstanding anything contained herein to the contrary, the Indemnitee hereby (i) agrees that it does not have any right, title,
interest or claim of any kind (each, a “Claim”) in or to any monies in the trust account established in connection with the Company’s initial public offering (the “IPO”) for the benefit of the
public shareholders of the Company and into which substantially all of the proceeds of the Company’s IPO will be deposited (the “Trust Account”), (ii) irrevocably waives any Claim it presently has or may have in the
future as a result of, or arising out of, any services provided by the Indemnitee to the Company, which Claim would reduce, encumber, or otherwise adversely affect the Trust Account or any monies or other assets in the Trust Account and
(iii) agrees that it will not seek recourse against the Trust Account or any monies or other assets in the Trust Account for any reason whatsoever. Accordingly, the Indemnitee acknowledges and agrees that any indemnification provided hereto
will only be able to be satisfied by the Company if the Company (i) has sufficient funds outside of the Trust Account to satisfy its obligations hereunder or (ii) consummates a Business Combination. 

28. MAINTENANCE OF INSURANCE 
 The Company
shall use commercially reasonable efforts to obtain and maintain in effect during the entire period for which the Company is obligated to indemnify the Indemnitee under this Agreement, one or more policies of insurance with reputable insurance
companies to provide the officers/directors of the Company with coverage for losses from wrongful acts and omissions and to ensure the Company’s performance of its indemnification obligations under this Agreement. The Indemnitee shall be
covered by such policy or policies in accordance with its or their terms to the maximum extent of the coverage available for any such director or officer under such policy or policies. In all such insurance policies, the Indemnitee shall be named as
an insured in such a manner as to provide the Indemnitee with the same rights and benefits as are accorded to the most favorably insured of the Company’s directors and officers. 

[SIGNATURE PAGE FOLLOWS] 

 IN WITNESS WHEREOF, the parties hereto have caused this Indemnity Agreement to be signed as
of the day and year first above written. 
  

			
	ISRAEL AMPLIFY PROGRAM CORP.
		
	By:	 	
                     
    

 
			
	Name:
	Title:
	
	INDEMNITEE
	
	
                     
                                         
   

	Name:
	Address:

 [Signature Page to Indemnity Agreement]EX-10.9

 Exhibit 10.9 

May 13, 2021 
 Israel Amplify Program Corp. 

c/o Sphera Fund 
 10 E. 53rd Street, Suite 1301 

New York, New York 10022 
 Re: Initial Public Offering

 Ladies and Gentlemen: 
 This letter (this
“Letter Agreement”) is being delivered to you in accordance with the Underwriting Agreement (the “Underwriting Agreement”) entered into by and among Israel Amplify Program Corp., a Cayman Islands
exempted company (the “Company”), Cowen and Company, LLC, as underwriter (the “Underwriter”), relating to an underwritten initial public offering (the “Public Offering”) of
23,000,000 of the Company’s units (including 3,000,000 units that may be purchased pursuant to the Underwriter’s option to purchase additional units to cover over-allotments, if any) (the “Units”), each comprised of
one share of the Company’s Class A ordinary shares, par value $0.0001 per share (the “Class A Ordinary Shares”), and one-fifth of one
redeemable warrant. Each whole warrant (each, a “Warrant”) entitles the holder thereof to purchase one Class A Ordinary Share at a price of $11.50 per share, subject to adjustment. The Units will be sold in the Public
Offering pursuant to a Registration Statement on Form S-1 and a related prospectus (the “Prospectus”) filed by the Company with the U.S. Securities and Exchange Commission (the
“Commission”). Certain capitalized terms used herein are defined in paragraph 1 hereof. 
 In order to induce the
Company and the Underwriter to enter into the Underwriting Agreement and to proceed with the Public Offering and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, AOP SPAC, Limited Partnership,
an Israeli limited partnership (“Amplify-Israel”), ISAP Acquisition LP, a Cayman Islands exempted limited partnership (“Amplify-Caymans”), Pitango Acquisition Corporation Limited Partnership, an
Israeli limited partnership (“Pitango”), Sphera SPAC, Limited Partnership, an Israeli limited partnership (“Sphera”, and together with Amplify-Israel, Amplify-Caymans and Pitango, the
“Sponsors” and each, a “Sponsor”) and each of the undersigned individuals, each of whom is or will be a member of the Company’s board of directors (the “Board”) and/or
management team (each, an “Insider” and, collectively, the “Insiders”), hereby agree with the Company, severally and not jointly, as follows: 

1. Definitions. As used herein, (i) “affiliate” shall mean an affiliate within the meaning of Rule 405 under the
Securities Exchange Act of 1934, as amended; (ii) “Business Combination” shall mean a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination involving the Company and one or
more businesses; (iii) “Founder Shares” shall mean the 5,750,000 Class B ordinary shares of the Company, par value $0.0001 per share, outstanding prior to the consummation of the Public Offering (up to 750,000 of which
are subject to complete or partial forfeiture if the Underwriter’s over-allotment option is not exercised in full); (iv) “Private Placement Warrants” shall mean the 6,000,000 warrants to purchase up to 6,000,000
Class A Ordinary Shares of the Company (or 6,600,000 warrants to purchase up to 6,600,000 Class A Ordinary Shares of the Company if the Underwriter’s over-allotment option is exercised in full), at a price of $1.00 per Warrant, for an
aggregate price of $6,000,000 (or $6,600,000 if the Underwriter’s over-allotment option is exercised in full), with respect to which (a) each of the Sponsors entered into a Private Placement Warrants Purchase Agreement with the Company
pursuant to which the Sponsors have purchased in private placement transactions an aggregate of 5,217,391 Private Placement Warrants (and have, severally but not jointly, agreed to purchase an additional 521,739 Private Placement Warrants if the
Underwriter’s over-allotment option is exercised in full) and (b) certain funds and accounts managed by subsidiaries of BlackRock, Inc. (“BlackRock”) entered into that certain Private Placement Warrants Purchase
Agreement with the Company pursuant to which BlackRock has agreed to purchase 782,609 Private Placement Warrants (or up to 860,870 Private Placement Warrants if the Underwriter’s over-allotment option is exercised in full); (v)
“Public Shareholders” shall mean the holders of Class A Ordinary Shares included in the Units issued in the Public Offering; (vi) “Public Shares” shall mean the Class A Ordinary Shares
included in the Units issued in the 

 
Public Offering; (vii) “Trust Account” shall mean the trust account into which a portion of the net proceeds of the Public Offering and the sale of the Private Placement
Warrants shall be deposited; (viii) “Termination Date” shall mean the earlier of (a) the liquidation of the Company and (b) the consummation by the Company of an initial Business Combination; (ix)
“Transfer” shall mean the (a) sale or assignment of, offer to sell, contract or agreement to sell, hypothecate, pledge, grant of any option to purchase or otherwise dispose of or agreement to dispose of, directly or
indirectly, or establishment or increase of a put equivalent position or liquidation with respect to or decrease of a call equivalent position within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, and the rules
and regulations of the Commission promulgated thereunder with respect to, any security, (b) entry into any swap or other arrangement that transfers to another, in whole or in part, any of the economic consequences of ownership of any security,
whether any such transaction is to be settled by delivery of such securities, in cash or otherwise, or (c) public announcement of any intention to effect any transaction specified in clause (a) or (b); (x) “Charter”
shall mean the Company’s Amended and Restated Memorandum and Articles of Association, as the same may be amended from time to time; and (xi) “Forward Purchase Shares”, “Forward Purchase Warrants”,
“Forward Purchase Securities”, “Forward Purchase Agreement” and “Sphera Fund” shall have the meaning ascribed to each such term in the Underwriting Agreement. 

2. Representations and Warranties.  

(a) (i) Each Sponsor and each Insider, with respect to itself, represents and warrants to the Company that it has the full right and
power, without violating any agreement by which it is bound (including, without limitation, any non-competition or non-solicitation agreement with any employer or former
employer), to enter into this Letter Agreement, and (ii) each Insider, with respect to itself, (1) represents and warrants to the Company that it has the full right and power, without violating any agreement by which it is bound
(including, without limitation, any non-competition or non-solicitation agreement with any employer or former employer), to serve as an officer of the Company and/or a
director on the Company’s Board, as applicable, and (2) consents to being named in the Prospectus, road show and any other materials as an officer and/or director of the Company, as applicable. 

(b) Each Insider represents and warrants, with respect to itself, that (i) such Insider’s biographical information furnished to the
Company (including any such information included in the Prospectus) is true and accurate in all material respects and does not omit any material information with respect to such Insider’s background, (ii) such Insider’s questionnaire
furnished to the Company is true and accurate in all material respects, (iii) such Insider is not subject to or a respondent in any legal action for, any injunction,
cease-and-desist order or order or stipulation to desist or refrain from any act or practice relating to the offering of securities in any jurisdiction, (iv) such
Insider has never been convicted of, or pleaded guilty to, any crime (1) involving fraud, (2) relating to any financial transaction or handling of funds of another person, or (3) pertaining to any dealings in any securities, and such
Insider is not currently a defendant in any such criminal proceeding, and (v) such Insider has never been suspended or expelled from membership in any securities or commodities exchange or association or had a securities or commodities license
or registration denied, suspended or revoked. 
 3. Business Combination Vote. Each Sponsor and each Insider, with respect to itself,
agrees that if the Company seeks shareholder approval of a proposed initial Business Combination, then in connection with such proposed initial Business Combination, it shall vote all Founder Shares and any Public Shares held by it in favor of such
proposed initial Business Combination (including any proposals recommended by the Board in connection with such proposed initial Business Combination) and not redeem any Founder Shares or Public Shares held by it in connection with such shareholder
approval. 
 4. Failure to Consummate a Business Combination; Trust Account Waiver. 

(a) Each Sponsor and each Insider hereby agrees, with respect to itself, that in the event that the Company fails to consummate an initial
Business Combination within 24 months from the closing of the Public Offering, or such later period approved by the Company’s shareholders in accordance with the Charter (the “Outside Date”), each Sponsor and each
Insider shall take all reasonable steps to cause the Company to (i) cease all operations except for the purpose of winding up; (ii) as promptly as reasonably possible but not more than 10 business days after the Outside Date, redeem 100%
of the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned on the funds held in the Trust Account and not
previously released to the Company to pay its taxes, if any (minus up to $100,000 of interest to pay dissolution expenses), divided by the number of then-outstanding Public Shares, which redemption will completely extinguish

 
all Public Shareholders’ rights as shareholders (including the right to receive further liquidation distributions, if any); and (iii) as promptly as reasonably possible following such
redemption, subject to the approval of the Company’s remaining shareholders and the Board, liquidate and dissolve, subject in each case, to the Company’s obligations under Cayman Islands law to provide for claims of creditors and in all
cases subject to the other requirements of applicable law. Each Sponsor and each Insider, severally and not jointly, agrees not to propose any amendment to the Charter (i) that would modify the substance or timing of the Company’s
obligation to provide holders of the Public Shares the right to have their Public Shares redeemed in connection with an initial Business Combination or to redeem 100% of the Public Shares if the Company does not complete an initial Business
Combination by the Outside Date or (ii) with respect to any other provision relating to the rights of holders of Public Shares, unless the Company provides its Public Shareholders with the opportunity to redeem their Public Shares upon approval
of any such amendment at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned on the funds held in the Trust Account and not
previously released to the Company to pay taxes, if any, divided by the number of then-outstanding Public Shares. 
 (b) Each Sponsor and
each Insider, with respect to itself, acknowledges that it has no right, title, interest or claim of any kind in or to the Trust Account or any monies or other assets held in the Trust Account or any other asset of the Company as a result of any
liquidation of the Company with respect to the Founder Shares held by it, if any. Each Sponsor and each Insider hereby further waives, with respect to any Founder Shares and Public Shares held by it, any redemption rights it may have in connection
with the consummation of an initial Business Combination, including, without limitation, any such rights available in the context of a shareholder vote to approve such initial Business Combination or a shareholder vote to approve an amendment to the
Charter (i) that would modify the substance or timing of the Company’s obligation to provide holders of the Public Shares the right to have their Public Shares redeemed in connection with an initial Business Combination or to redeem 100%
of the Public Shares if the Company has not consummated an initial Business Combination by the Outside Date or (ii) with respect to any other provision relating to the rights of holders of Public Shares. For the avoidance of doubt, each Sponsor
and each Insider shall be entitled to liquidation rights with respect to any Public Shares they hold if the Company fails to consummate an initial Business Combination by the Outside Date. 

5. Lock-up; Transfer Restrictions.  

(a) Each Sponsor and each Insider, severally and not jointly, agrees that it shall not Transfer any Founder Shares (the “Founder
Shares Lock-up”) until the earliest of (A) one year after the completion of an initial Business Combination and (B) subsequent to an initial Business Combination, the date on which
(x) the closing price of the Company’s Class A Ordinary Shares equals or exceeds $12.00 per share (as adjusted for share subdivisions, share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days
within any 30-trading day period commencing at least 150 days after the initial Business Combination or (y) the Company completes a liquidation, merger, share exchange or other similar transaction that
results in all of the Company’s Public Shareholders having the right to exchange their Public Shares for cash, securities or other property (the “Founder Shares Lock-up Period”).

 (b) Each Sponsor and each Insider, severally and not jointly, agrees that it shall not Transfer any Private Placement Warrants (including
the Class A Ordinary Shares issuable upon exercise of such Private Placement Warrants) until 30 days after the completion of an initial Business Combination (the “Private Placement Units
Lock-up Period” and, together with the Founder Shares Lock-up Period, the “Lock-up
Periods”). 
 (c) Notwithstanding the provisions set forth in paragraphs 5(a) and 5(b), Transfers of the Founder Shares, Private
Placement Warrants and Class A Ordinary Shares underlying the Private Placement Warrants are permitted (a) to the Company’s officers or directors, any affiliate or family member of any of the Company’s officers or directors, any
members or partners of the Sponsors or their respective affiliates, any affiliates of the Sponsors, any employees or directors of such affiliates or any funds or accounts advised by the Sponsors or their respective affiliates, or to any Sponsor;
(b) in the case of an individual, by gift to a member of one of the individual’s immediate family or to a trust, the beneficiary of which is a member of the individual’s immediate family, an affiliate of such person or to a charitable
organization; (c) in the case of an individual, by virtue of laws of descent and distribution upon death of the individual; (d) in the case of an individual, pursuant to a qualified domestic relations order; (e) by private sales or
transfers made in connection with the consummation of an initial Business Combination at prices no greater than the price at which the Founder Shares, Private Placement Warrants or Class A Ordinary Shares, as applicable,

 
were originally purchased; (f) in the case of a Sponsor, by virtue of the laws of the Cayman Islands, the laws of Israel or a Sponsor’s organizational documents upon liquidation or
dissolution of any Sponsor; (g) in the case of a Sponsor, as a distribution to members or limited partners of a Sponsor; (h) to the Company for no value for cancellation in connection with the consummation of an initial Business
Combination; (i) in the event of the Company’s liquidation prior to the completion of an initial Business Combination; or (j) in the event of completion of a liquidation, merger, share exchange or other similar transaction which
results in all of the Company’s Public Shareholders having the right to exchange their Public Shares for cash, securities or other property subsequent to the completion of an initial Business Combination; provided, however, that
in the case of clauses (a) through (g) such permitted transferees must enter into a written agreement agreeing to be bound by the transfer restrictions set forth in this Letter Agreement and the other restrictions contained in this Letter
Agreement (including provisions relating to voting, the Trust Account and liquidating distributions). 
 (d) During the period commencing on
the effective date of the Underwriting Agreement and ending 180 days after such date, each Sponsor and each Insider shall not, without the prior written consent of the Underwriter, Transfer any Units, Class A Ordinary Shares, Warrants or any
other securities convertible into, or exercisable or exchangeable for, Class A Ordinary Shares held by it, subject to certain exceptions enumerated in Section 4(h) of the Underwriting Agreement. The provisions of this paragraph
(d) will not apply to (i) any transfer permitted under paragraph 5(c) hereof or (ii) any transfer of Forward Purchase Shares or Forward Purchase Warrants, or any transfer or assignment by Sphera Fund of its right and obligation to
purchase Forward Purchase Securities pursuant to the Forward Purchase Agreement. 
 6. License. 

(a) Amplify-Israel, on behalf of itself and its affiliates, grants to the Company a non-exclusive,
fully paid-up, royalty-free, non-sublicensable and non-transferable limited license, until the Termination Date, to use any
rights it has in the “Amplify” trademark and the Amplify logo solely in marketing materials and on its websites (including in combination with the licensed trademarks and logos licensed pursuant to paragraphs 6(b) and 6(c) and to hold
itself out as “Israel Amplify Program Corp.”. Any goodwill accruing from the Company’s use of the licensed trademark and logo will inure solely to Amplify-Israel and its affiliates. 

(b) Pitango, on behalf of itself and its affiliates, grants to the Company a non-exclusive, fully paid-up, royalty-free, non-sublicensable and non-transferable limited license, until the Termination Date, to use any rights it has in
the “Pitango” trademark and the Pitango logo solely in marketing materials and on its websites (including in combination with the licensed trademarks and logos licensed pursuant to paragraphs 6(a) and 6(c). Any goodwill accruing from the
Company’s use of the licensed trademark and logo will inure solely to Pitango and its affiliates. 
 (c) Sphera, on behalf of itself and
its affiliates, grants to the Company a non-exclusive, fully paid-up, royalty-free, non-sublicensable and non-transferable limited license, until the Termination Date, to use any rights it has in the “Sphera” trademark and the Sphera logo solely in marketing materials and on its websites (including in
combination with the licensed trademarks and logos licensed pursuant to paragraphs 6(a) and 6(b). Any goodwill accruing from the Company’s use of the licensed trademark and logo will inure solely to Sphera and its affiliates. 

7. Remedies. Each Sponsor and each Insider, severally and not jointly, hereby agrees and acknowledges that (i) the Underwriter, the
other Sponsors and the Company would be irreparably injured in the event of a breach by any Sponsor or such Insider of its obligations, as applicable, under paragraphs 3, 4, 5, 8, 11 and 13, (ii) monetary damages may not be an adequate remedy for
such breach and (iii) the non-breaching party shall be entitled to injunctive relief, in addition to any other remedy that such party may have in law or in equity, in the event of such breach. 

8. Payments by the Company. Except as disclosed in the Prospectus, neither any Sponsor nor any director or officer of the Company
or any of their respective affiliates shall receive from the Company any finder’s fee, reimbursements or cash payments prior to, or in connection with, the initial Business Combination. 

9. Director and Officer Liability Insurance. The Company will maintain an insurance policy or policies providing directors’ and
officers’ liability insurance, and each Insider shall be covered by such policy or policies, in accordance with its or their terms, to the maximum extent of the coverage available for any of the Company’s directors or officers. 

 10. Termination. This Letter Agreement shall terminate on the earlier of (i) the
expiration of each of the Lock-up Periods and (ii) the liquidation of the Company; provided that this Letter Agreement shall earlier terminate in the event that the Public Offering is not
consummated by September 30, 2021; provided, further, that paragraph 10 of this Letter Agreement shall survive any such liquidation. 

11. Indemnification. In the event of the liquidation of the Trust Account upon the failure of the Company to consummate its initial
Business Combination within the time period set forth in the Charter, the Sponsors (the “Indemnitors” and each an “Indemnitor”), severally (up to such Indemnitor’s Proportionate Share) and not
jointly, agree to indemnify and hold harmless the Company against any and all loss, liability, claim, damage and expense whatsoever (including, but not limited to, any and all legal or other expenses reasonably incurred in investigating, preparing
or defending against any litigation, whether pending or threatened) to which the Company may become subject as a result of any claim by (i) any third party for services rendered or products sold to the Company (except for the Company’s
independent auditors) (a “Qualified Third Party”) or (ii) any prospective target business with which the Company has discussed entering into a transaction agreement (a “Target”); provided,
however, that such indemnification of the Company by the Indemnitors (x) shall apply only to the extent necessary to ensure that such claims by a Qualified Third Party or a Target do not reduce the amount of funds in the Trust Account to
below the lesser of (i) $10.00 per Public Share and (ii) the actual amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account if less than $10.00 per Public Share due to reductions in the value of
the trust assets, in each case net of interest that may be withdrawn to pay the Company’s tax obligations, (y) shall not apply to any claims by a Qualified Third Party or a Target who executed a waiver of any and all rights to the monies
held in the Trust Account (whether or not such waiver is enforceable) and (z) shall not apply to any claims under the Company’s indemnity of the Underwriter against certain liabilities, including liabilities under the Securities Act of
1933, as amended. “Proportionate Share”, with respect to an Indemnitor, means the percentage of Founder Shares held by such Indemnitor as of the date hereof relative to the aggregate number of Founder Shares held by all
Indemnitors as of the date hereof.The Indemnitors shall have the right to defend against any such claim with counsel of their choice reasonably satisfactory to the Company if, within 15 days following written receipt of notice of the claim to each
Indemnitor, each such Indemnitor notifies the Company in writing that it shall undertake such defense. For the avoidance of doubt, none of the Company’s officers or directors will indemnify the Company for claims by third parties, including,
without limitation, claims by vendors and prospective target businesses. 
 12. Forfeiture of Founder Shares. To the extent that the
Underwriter does not exercise its over-allotment option in full to purchase additional Units within 45 days from the date of the Prospectus (as further described in the Prospectus), each Sponsor agrees to automatically surrender to the Company for
no consideration, for cancellation at no cost, its pro rata share of up to 750,000 Founder Shares in the aggregate, such that the number of Founder Shares will equal 20% of the sum of the total number of Class A Ordinary Shares and Founder
Shares outstanding at such time. Each Sponsor and each Insider, severally and not jointly, further agrees that to the extent that the size of the Public Offering is increased or decreased, the Company will effect a share capitalization or a share
repurchase, as applicable, with respect to the Founder Shares immediately prior to the consummation of the Public Offering in such amount as to maintain the number of Founder Shares at 20% of the sum of the total number of Class A Ordinary
Shares and Founder Shares outstanding at such time. 
 13. Entire Agreement. This Letter Agreement constitutes the entire agreement
and understanding of the parties hereto in respect of the subject matter hereof and supersedes all prior understandings, agreements, or representations by or among the parties hereto, written or oral, to the extent they relate in any way to the
subject matter hereof or the transactions contemplated hereby. This Letter Agreement may not be changed, amended, modified or waived (other than to correct a typographical error) as to any particular provision, except by a written instrument
executed by (i) each Insider that is affected by such change, amendment, modification or waiver and (ii) each Sponsor. 
 14.
Assignment. No party hereto may assign either this Letter Agreement or any of its rights, interests, or obligations hereunder without the prior written consent of the other parties hereto. Any purported assignment in violation of this
paragraph shall be void and ineffectual and shall not operate to transfer or assign any interest or title to the purported assignee. This Letter Agreement shall be binding on each Sponsor, each of the Insiders and each of their respective
successors, heirs, personal representatives and assigns and permitted transferees. 

 15. Additional Parties. Additional parties may be added to this Letter Agreement upon
receipt by the Company of such party’s written agreement, in a form reasonably satisfactory to the Company, to be bound by the terms and provisions of this Letter Agreement (which may be accomplished by an addendum or certificate of joinder to
this Letter Agreement). 
 16. No Third Party Beneficiaries. Nothing in this Letter Agreement shall be construed to confer upon, or
give to, any person or entity other than the parties hereto, any right, remedy or claim under or by reason of this Letter Agreement or of any covenant, condition, stipulation, promise or agreement hereof. All covenants, conditions, stipulations,
promises and agreements contained in this Letter Agreement shall be for the sole and exclusive benefit of the parties hereto and their successors, heirs, personal representatives and assigns and permitted transferees;
provided, however, that the Underwriter shall benefit from the provisions set forth in paragraph 5(d), which such paragraph shall not be amended or modified without the written consent of the Underwriter. 

17. Counterparts. The parties hereto may sign any number of copies of this Letter Agreement. Each signed copy will be an original, and
all of them together represent the same agreement. Delivery of an executed counterpart of this Letter Agreement by facsimile, electronically in portable document format or in any other format will be effective as delivery of a manually or
electronically executed counterpart. As used in this Letter Agreement, the words “execution”, “signed”, “signature”, “delivery” and words of like import in or relating to any document to be signed in
connection with this Letter Agreement and the transactions contemplated hereby or thereby shall be deemed to include Electronic Signatures, deliveries or the keeping of records in electronic form, each of which shall be of the same legal effect,
validity or enforceability as a manually executed signature, physical delivery thereof or the use of a paper-based recordkeeping system, as the case may be, to the extent and as provided for in any applicable law, including the Federal Electronic
Signatures in Global and National Commerce Act, the New York State Electronic Signatures and Records Act, or any other similar state laws based on the Uniform Electronic Transactions Act. As used herein, “Electronic Signature” means an
electronic sound, symbol, or process attached to, or associated with, a contract or other record and adopted by a person with the intent to sign, authenticate or accept such contract or other record. 

18. Effect of Headings. The paragraph headings herein are for convenience only and are not part of this Letter Agreement and shall not
affect the interpretation thereof. 
 19. Severability. This Letter Agreement shall be deemed severable, and the invalidity or
unenforceability of any term or provision hereof shall not affect the validity or enforceability of this Letter Agreement or of any other term or provision hereof. Furthermore, in lieu of any such invalid or unenforceable term or provision, the
parties hereto intend that there shall be added as a part of this Letter Agreement a provision as similar in terms to such invalid or unenforceable provision as may be possible and be valid and enforceable. 

20. Governing Law. This Letter Agreement shall be governed by and construed and enforced in accordance with the laws of the State of New
York, without giving effect to conflicts of law principles that would result in the application of the substantive laws of another jurisdiction. The parties hereto (i) all agree that any action, proceeding, claim or dispute arising out of, or
relating in any way to, this Letter Agreement shall be brought and enforced in the courts of New York City, in the State of New York, and irrevocably submit to such jurisdiction and venue, which jurisdiction and venue shall be exclusive, and
(ii) waive any objection to such exclusive jurisdiction and venue or that such courts represent an inconvenient forum. 
 21.
Notices. Any notice, consent or request to be given in connection with any of the terms or provisions of this Letter Agreement shall be in writing and shall be sent by express mail or similar private courier service, by certified mail (return
receipt requested), by hand delivery or by facsimile or other electronic transmission. 
 Notice to the Company shall be given to it at: 

Israel Amplify Program Corp. 
 c/o
Sphera Fund 
 10 E. 53rd Street, Suite 1301 

New York, NY 10022 
 Attn: Asher
Levy, Chief Executive Officer 

 With a copy to: 

Cravath, Swaine & Moore LLP 

825 Eighth Avenue 
 New York, NY
10019 
 Attn: Nicholas A. Dorsey and Matthew G. Jones 

Notice to an Insider shall be given to it at: 

Israel Amplify Program Corp. 

c/o [Applicable Insider] 
 10 E.
53rd Street, Suite 1301 
 New York, NY 10022 

Attn: [Applicable Insider] 
 With a copy to: 

Cravath, Swaine & Moore LLP 

825 Eighth Avenue 
 New York, NY
10019 
 Attn: Nicholas A. Dorsey and Matthew G. Jones 

Notice to Amplify-Israel shall be given to it at: 

AOP SPAC, Limited Partnership 

Platinum House, 21 Ha’arba’ah Street, 

Tel Aviv 64739, Israel 
 Attn:
Amichai Steimberg 
 With a copy to: 
 AOP
SPAC Ltd. 
 c/o Abraham Gross 

10 Recanati Street 
 Tel Aviv
6949410 
 Israel 
 Attn:
Amichai Steimberg 
 Notice to Amplify-Caymans shall be given to it at: 

c/o Maples Corporate Services 

Limited, PO Box 309, Ugland House, 

Grand Cayman, KY1-1104, 

Cayman Islands 
 Attn: LizabethAnn
R. Eisen 
 With a copy to: 
 LMFR LLC 

PO Box 4901 
 Jackson, WY 83001

 Attn: LizabethAnn R. Eisen 
 Notice to
Pitango shall be given to it at: 
 Pitango Acquisition Corporation Limited Partnership 

1, Hamenofim Street 
 Herzliya,
Israel 
 Attn: Chemi Peres, Zeev Binman and Elana Barzilay 

 Notice to Sphera shall be given to it at: 

Sphera SPAC, Limited Partnership 

c/o Sphera Fund 
 21
Ha’arba’ah St. 
 Tel Aviv, Israel 6473921 

Attn: Ron Senator 
 With a copy to: 

Adi Hanetz 
 c/o Sphera Fund 

21 Ha’arba’ah St. 
 Tel
Aviv, Israel 6473921 
 22. No Liability for Other Parties. No party hereto shall be liable for any breaches or misrepresentations
contained in this Letter Agreement by any other party hereto (including, for the avoidance of doubt, any Insider with respect to any other Insider), and no party hereto shall be liable or responsible for the obligations of another party hereto,
including, without limitation, indemnification obligations and notice obligations. 
 [Signature Page Follows] 

 
					
		 	Sincerely,
		 	ISAP ACQUISITION LP
		
	By:	 	 /s/ LizabethAnn R. Eisen

		
		 	 For and on behalf of
 ISAP
ACQUISITION GP LLC
 As a general partner, on behalf of
 ISAP
Acquisition LP

		
		 	 PITANGO ACQUISITION CORPORATION LIMITED PARTNERSHIP,

an Israeli limited partnership

		
	By:	 	 /s/ Nechemia (Chemi) J. Peres

		 	Name: Nechemia (Chemi) J. Peres
		 	Title:
		
		 	 SPHERA SPAC, LIMITED PARTNERSHIP,

an Israeli limited partnership

		
		 	By Sphera SPAC holdings LTD, as general partner
		
	By:	 	 /s/ Ron Senator

		 	Name: Ron Senator
		 	Title: Managing Partner
		
	By:	 	 /s/ Neomi Elpelg

		 	Name: Neomi Elpelg
		 	Title: CFO
		
		 	 AOP SPAC, LIMITED PARTNERSHIP,

an Israeli limited partnership

		
	By:	 	 /s/ Amichai Steimberg

		
		 	 For and on behalf of
 AOP SPAC
LTD
 As general partner, on behalf of
 AOP SPAC, Limited
Partnership

		
		 	 /s/ Nechemia (Chemi) J. Peres

		 	Nechemia J. Peres
		
		 	 /s/ Rami Kalish

		 	Rami Kalish
		
		 	 /s/ LizabethAnn R. Eisen

		 	LizabethAnn R. Eisen

  

  
 [Signature Page to
Insider Letter] 

 
	
	
	 /s/ Asher Levy

	Asher Levy
	
	 /s/ Amichai Steimberg

	Amichai Steimberg
	
	 /s/ Timothy P. Surzyn

	Timothy P. Surzyn
	
	 /s/ Abraham Gross

	Abraham Gross
	
	 /s/ Craig S. Ivey

	Craig S. Ivey
	
	 /s/ Alexis Maged

	Alexis Maged
	
	 /s/ Charles Federman

	Charles Federman
	
	 /s/ Lisbeth R. McNabb

	Lisbeth R. McNabb

  

			
	Acknowledged and Agreed:
	
	ISRAEL AMPLIFY PROGRAM CORP.
	
	 /s/ Timothy P. Surzyn

	By:	 	
	Name:	 	Timothy P. Surzyn
	Title:	 	CFO

  

  
 [Signature Page to
Insider Letter]

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00327-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00327-of-00352.parquet"}]]